首页> JCO precision oncology> Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.

Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Toby,Trahair

第一单位： Sydney Children's Hospital, Randwick, New South Wales, Australia.;Children's Cancer Institute, Sydney, New South Wales, Australia.;University of New South Wales, Sydney, New South Wales, Australia.

作者： Toby,Trahair ^[1] ; Andrew J,Gifford ^[2] ; Ashleigh,Fordham ^[3] ; Chelsea,Mayoh ^[3] ; Mitali,Fadia ^[4] ; Robyn,Lukeis ^[5] ; Andrew C,Wood ^[6] ; Santosh,Valvi ^[7] ; Roderick D,Walker ^[8] ; James,Blackburn ^[9] ; Erin E,Heyer ^[10] ; Tim R,Mercer ^[11] ; Draga,Barbaric ^[12] ; Glenn M,Marshall ^[1] ; Karen L,MacKenzie ^[13]

作者单位： Sydney Children's Hospital, Randwick, New South Wales, Australia.;Children's Cancer Institute, Sydney, New South Wales, Australia.;University of New South Wales, Sydney, New South Wales, Australia. ^[1] Children's Cancer Institute, Sydney, New South Wales, Australia.;Prince of Wales Hospital, Randwick, New South Wales, Australia. ^[2] Children's Cancer Institute, Sydney, New South Wales, Australia. ^[3] Canberra Hospital, Garran, Australian Capital Territory, Australia.;Australian National University Medical School, Acton, Australian Capital Territory, Australia. ^[4] St Vincent's Hospital, Darlinghurst, New South Wales, Australia. ^[5] University of Auckland, Auckland, New Zealand. ^[6] Perth Children's Hospital, Perth, Western Australia, Australia. ^[7] Queensland Children's Hospital, South Brisbane, Queensland, Australia. ^[8] University of New South Wales, Sydney, New South Wales, Australia.;Garvan Institute of Medical Research, Sydney, New South Wales, Australia. ^[9] Garvan Institute of Medical Research, Sydney, New South Wales, Australia. ^[10] University of New South Wales, Sydney, New South Wales, Australia.;Garvan Institute of Medical Research, Sydney, New South Wales, Australia.;Altius Institute for Biomedical Sciences, Seattle, WA. ^[11] Sydney Children's Hospital, Randwick, New South Wales, Australia. ^[12] Children's Medical Research Institute, Westmead New South Wales, Australia. ^[13]

DOI 10.1200/PO.18.00297

PMID 32914017

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2019年3卷

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

JCO precision oncology

2019年3卷

检索历史清除

Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.

JCO precision oncology

相似文献

同项目论文

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.

JCO precision oncology

相似文献

同项目论文

JCO precision oncology

相关期刊

检索历史清除